¼¼°èÀÇ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ½ÃÀå
Acetaminophen
»óǰÄÚµå : 1773960
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 468 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 129¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 105¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 3.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 129¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Á¤Á¦´Â CAGR 4.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 56¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾×»ó ÇöŹ¾× ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 28¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ½ÃÀåÀº 2024³â¿¡´Â 28¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 6.6%·Î ¼ºÀåÇÏ¿© 2030³â±îÁö 26¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.3%¿Í 2.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÌ ÅëÁõ ¹× ¹ß¿­ °ü¸®ÀÇ ÇÙ½ÉÀÎ ÀÌÀ¯´Â?

ÁøÅë ¹× ÇØ¿­ ÀÛ¿ëÀ¸·Î ³Î¸® ¾Ë·ÁÁø ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀº °æÁõ¿¡¼­ ÁߵÀÇ ÅëÁõ°ú ¹ß¿­À» Ä¡·áÇϱâ À§ÇØ Àü ¼¼°èÀûÀ¸·Î °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â ÀǾàǰ Áß ÇϳªÀÔ´Ï´Ù. ÀϹÝÀǾàǰÀ¸·Î ½±°Ô ±¸ÇÒ ¼ö ÀÖ°í, 󹿾à°ú º´¿ë¿ä¹ýµµ °¡´ÉÇϱ⠶§¹®¿¡ Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ±× ¿ªÇÒÀÌ È®°íÈ÷ ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ¸¸¼º ÅëÁõ°ú °ñ°üÀý¿° ¹× ÆíµÎÅë°ú °°Àº »ýȰ½À°üº´ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀº Áö½ÃµÈ ´ë·Î »ç¿ëÇßÀ» ¶§ È¿°ú¿Í ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏ·Î ÀÎÇØ Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Áõ»ó¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ´ÙÀç´Ù´ÉÇÔÀ¸·Î ÀÎÇØ °¡Á¤ ³» ¾à»óÀÚ³ª ÀÓ»ó ÇöÀå¿¡¼­µµ ±× Á¸Àç°¨ÀÌ Á¡Á¡ ´õ Ä¿Áö°í ÀÖ½À´Ï´Ù.

±ÔÁ¦¿Í ±â¼úÀû ¿äÀÎÀÌ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ »ý»ê¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?

±ÔÁ¦ Áؼö¿Í ±â¼ú ¹ßÀüÀº ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ½ÃÀåÀ» Çü¼ºÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í º¸°Ç ±â°üÀº ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ Á¦Ç°ÀÇ ¾ÈÀü¼º°ú È¿´ÉÀ» º¸ÀåÇϱâ À§ÇØ Ç°Áú ±âÁØÀ» °­È­Çϰí ÀÖÀ¸¸ç, Á¦Á¶¾÷ü°¡ ÷´Ü »ý»ê °øÁ¤À» äÅÃÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ±×¸° Äɹ̽ºÆ®¸® ±â¼úÀº ÃÖÁ¾ Á¦Ç°ÀÇ °í¼øµµ ¼öÁØÀ» À¯ÁöÇϸ鼭 ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀ̰í, ȯ°æ ģȭÀûÀ̶ó´Â Á¡¿¡¼­ ¸¹Àº ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀǾàǰ Á¦Á¦ ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼­¹æÇü Á¦Á¦ ¹× º¹ÇÕÁ¦ °³¹ßÀÌ °¡´ÉÇØÁ® ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ Á¦Ç°ÀÇ Ä¡·á È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀº ÁøÈ­ÇÏ´Â ¼ÒºñÀÚ ´ÏÁî¿Í ±ÔÁ¦ ¿ä°Ç¿¡ ´ëÇÑ ÀûÀÀ¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ½ÃÀåÀÇ »õ·Î¿î ¿ëµµ¿Í µ¿ÇâÀº?

¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÇ ¿ëµµ´Â ±âÁ¸ÀÇ ÅëÁõ ¿ÏÈ­³ª ÇØ¿­ °ü¸® ¿Ü¿¡µµ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÁßÁõ ÆíµÎÅëÀ̳ª ¼ö¼ú ÈÄ ÅëÁõ°ú °°Àº º¹ÀâÇÑ º´Å»ý¸®¸¦ °ü¸®Çϱâ À§ÇÑ º´¿ë¿ä¹ý¿¡ Æ÷ÇԵǴ °æ¿ì°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ Æ®·»µå´Â ÀþÀº ȯÀÚµéÀÇ Æ¯¼öÇÑ ´ÏÁî¿¡ ´ëÀÀÇϱâ À§ÇÑ ¼Ò¾Æ¿ë Á¦Á¦ °³¹ßÀÔ´Ï´Ù. ¶ÇÇÑ, COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È ³Î¸® »ç¿ëµÈ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÇ ¿ªÇÒÀº °¨¿°¼º ÁúȯÀÇ Áõ»ó °ü¸®¿¡ ÀÖ¾î ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÇ ¿ªÇÒÀÌ °øÁߺ¸°Ç¿¡ ÀÖ¾î ±× Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¹ßÆ÷¼º Á¤Á¦ ¹× Ãò¾îºí Á¤Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â º¸´Ù Æí¸®ÇÑ Á¦Çü¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£¸¦ ¹Ý¿µÇϰí ÀÖÀ¸¸ç, Á¦³×¸¯ ÀǾàǰ°ú Àú·ÅÇÑ °¡°ÝÀÇ ´ë¾È¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ Á¢±Ù¼ºÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ¸¸¼º ÅëÁõ ÁúȯÀÇ À¯º´·ü Áõ°¡, °èÀý¼º ¹× ¹ÙÀÌ·¯½º¼º ÁúȯÀÇ Áõ°¡·Î ÀÎÇØ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÌ 1Â÷ ¼±Åà ġ·áÁ¦·Î¼­ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀǾàǰ Á¦Á¶ÀÇ ¹ßÀü°ú ´Ù¾çÇÑ Á¦ÇüÀÇ °¡¿ë¼ºÀ¸·Î ÀÎÇØ ¼ÒºñÀÚ ±â¹ÝÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÆÇ ÀǾàǰÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇÑ ±ÔÁ¦Àû ³ë·ÂÀº ½Å·Ú¸¦ Çü¼ºÇÏ°í º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ½ÅÈï±¹ ½ÃÀå¿¡¼­ ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå °³Ã´¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÇ Ç¥Àû Ä¡·áÁ¦·ÎÀÇ ¹èÇÕÀº ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÇ ´ÙÀç´Ù´ÉÇÔÀ» ºÎ°¢½Ã۸ç Á¦¾à »ê¾÷¿¡¼­ ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæÀÇ Áö¼ÓÀûÀÎ °ü·Ã¼ºÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Çü(Á¤Á¦, ¾×»ó Çöʾ×, ÁÖÀÔ, ±âŸ Á¦Çü), Åõ¿© °æ·Î(°æ±¸ Åõ¿© °æ·Î, ±âŸ Åõ¿© °æ·Î), À¯Åë ä³Î(º´¿ø ¾à±¹, ¼Ò¸Å ¾à±¹, ¿Â¶óÀÎ ¾à±¹), ¿ëµµ(ÁøÅ롤¹ß¿­ ¿ëµµ, °¨±â ¿ëµµ, µÎÅë ¿ëµµ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°è °íÀ¯ÀÇ SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Acetaminophen Market to Reach US$12.9 Billion by 2030

The global market for Acetaminophen estimated at US$10.5 Billion in the year 2024, is expected to reach US$12.9 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Tablets Form, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Liquid Suspension Form segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 6.6% CAGR

The Acetaminophen market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Acetaminophen Market - Key Trends & Drivers Summarized

Why Is Acetaminophen a Cornerstone in Pain and Fever Management?

Acetaminophen, widely known for its analgesic and antipyretic properties, remains one of the most commonly used medications globally for the treatment of mild to moderate pain and fever. Its accessibility as an over-the-counter drug and its inclusion in prescription combination therapies have solidified its role in healthcare systems worldwide. As chronic pain conditions and the prevalence of lifestyle-related ailments such as osteoarthritis and migraines rise, acetaminophen is increasingly sought after for its efficacy and safety profile when used as directed. Its versatility in addressing a range of symptoms ensures its continued prominence in both household medicine cabinets and clinical settings.

How Are Regulatory and Technological Factors Influencing Acetaminophen Production?

Regulatory compliance and technological advancements are playing pivotal roles in shaping the acetaminophen market. Governments and health organizations have tightened quality standards to ensure the safety and efficacy of acetaminophen products, driving manufacturers to adopt advanced production processes. Green chemistry techniques are gaining traction, reducing environmental impact while maintaining high purity levels in the final product. Furthermore, advancements in pharmaceutical formulation technologies are enabling the development of extended-release and combination acetaminophen products, enhancing their therapeutic benefits. These innovations are making acetaminophen more adaptable to evolving consumer needs and regulatory requirements.

What Are the Emerging Applications and Trends in the Acetaminophen Market?

The applications of acetaminophen are expanding beyond its traditional use in pain relief and fever management. It is increasingly incorporated into combination therapies for managing complex conditions, such as severe migraines and postoperative pain. A significant trend is the development of pediatric formulations, catering to the unique needs of younger patients. Moreover, acetaminophen’s role in managing symptoms of infectious diseases, including its widespread use during the COVID-19 pandemic, underscores its critical importance in public health. The rising demand for effervescent and chewable tablets reflects consumer preferences for more convenient dosage forms, while the growing focus on generic and affordable options is expanding its reach in emerging markets.

What Drives the Growth of the Acetaminophen Market?

The growth in the Acetaminophen market is driven by several factors. The increasing prevalence of chronic pain conditions and the rise in seasonal and viral illnesses have boosted demand for acetaminophen as a first-line treatment. Advancements in pharmaceutical manufacturing and the availability of diverse formulations are expanding its consumer base. Regulatory efforts to ensure the safety and efficacy of over-the-counter medications are fostering trust and encouraging widespread use. Additionally, the rising focus on affordable healthcare solutions, particularly in developing regions, is further propelling market growth. The integration of acetaminophen into combination drugs for targeted therapies highlights its versatility and underscores its sustained relevance in the pharmaceutical landscape.

SCOPE OF STUDY:

The report analyzes the Acetaminophen market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage Form (Tablets Form, Liquid Suspension Form, Infusion Solution Form, Other Dosage Forms); Administration Route (Oral Administration Route, Other Administration Routes); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); Application (Pain Relief and Fever Application, Common Cold Application, Headache Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â